Ex vivo and preclinical data showed that DPP‐4is can restore the insulin‐induced vascular redox response and endothelial dysfunction, suggesting that the combination of a DPP‐4i and an insulin analogue might prevent atherosclerosis.18 The gene discussed is INS; the disease is atherosclerosis.